Product Information
TRANDOLAPRIL 2 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1622 per EA under NDC 68180056701. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 12, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180056701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TRANDOLAPRILApproval Type
Generic (ANDA)
FDA Application
ANDA077522FDA Approved
6/12/2007
TE Code
AB
On Market Since
6/11/2007
Pharmacological Classes
Price Statistics
The NADAC for TRANDOLAPRIL 2 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 31.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1622 per EA |
|---|---|
| All-time high | $0.3297 (Apr 14, 2021) |
| All-time low | $0.1326 (May 22, 2019) |
| 52-week high | $0.1951 |
| 52-week low | $0.1622 |
| Median price | $0.2155 |
| Average price | $0.2148 |
| Largest weekly change | +69.0% (Sep 18, 2019) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Trandolapril market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRANDOLAPRIL 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRANDOLAPRIL 2 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1622 per EA (NDC 68180056701), effective Sep 30, 2026.
How has the price of TRANDOLAPRIL 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRANDOLAPRIL 2 MG TABLET has declined 31.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRANDOLAPRIL 2 MG TABLET?
Since Nov 28, 2013, the NADAC for TRANDOLAPRIL 2 MG TABLET has ranged from a low of $0.1326 (May 22, 2019) to a high of $0.3297 (Apr 14, 2021), with a median of $0.2155 per EA.
Are there cheaper alternatives to TRANDOLAPRIL 2 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRANDOLAPRIL 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TRANDOLAPRIL 2 MG TABLET?
TRANDOLAPRIL 2 MG TABLET (NDC 68180056701) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.